250 related articles for article (PubMed ID: 26880715)
1. Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells.
Zdanov S; Mandapathil M; Abu Eid R; Adamson-Fadeyi S; Wilson W; Qian J; Carnie A; Tarasova N; Mkrtichyan M; Berzofsky JA; Whiteside TL; Khleif SN
Cancer Immunol Res; 2016 Apr; 4(4):354-65. PubMed ID: 26880715
[TBL] [Abstract][Full Text] [Related]
2. Kras
Cheng H; Fan K; Luo G; Fan Z; Yang C; Huang Q; Jin K; Xu J; Yu X; Liu C
Cancer Lett; 2019 Apr; 446():103-111. PubMed ID: 30664964
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer.
Kitai H; Ebi H; Tomida S; Floros KV; Kotani H; Adachi Y; Oizumi S; Nishimura M; Faber AC; Yano S
Cancer Discov; 2016 Jul; 6(7):754-69. PubMed ID: 27154822
[TBL] [Abstract][Full Text] [Related]
4. MiR-21 controls in situ expansion of CCR6⁺ regulatory T cells through PTEN/AKT pathway in breast cancer.
Hu Y; Wang C; Li Y; Zhao J; Chen C; Zhou Y; Tao Y; Guo M; Qin N; Ren T; Wen Z; Xu L
Immunol Cell Biol; 2015 Sep; 93(8):753-64. PubMed ID: 25735723
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells.
Komatsu N; Fujita Y; Matsuda M; Aoki K
Oncogene; 2015 Nov; 34(45):5607-16. PubMed ID: 25703330
[TBL] [Abstract][Full Text] [Related]
6. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
[TBL] [Abstract][Full Text] [Related]
7. Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer.
Shen L; Zhang LL; Li H; Liu X; Yu XX; Hu P; Hui H; Guo QL; Zhang S
Oncotarget; 2017 Jul; 8(30):49395-49408. PubMed ID: 28472762
[TBL] [Abstract][Full Text] [Related]
8. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.
Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM
J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.
Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS
Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096
[No Abstract] [Full Text] [Related]
10. IL22 Promotes
Khosravi N; Caetano MS; Cumpian AM; Unver N; De la Garza Ramos C; Noble O; Daliri S; Hernandez BJ; Gutierrez BA; Evans SE; Hanash S; Alekseev AM; Yang Y; Chang SH; Nurieva R; Kadara H; Chen J; Ostrin EJ; Moghaddam SJ
Cancer Immunol Res; 2018 Jul; 6(7):788-797. PubMed ID: 29764837
[TBL] [Abstract][Full Text] [Related]
11. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
12. The GARP/Latent TGF-β1 complex on Treg cells modulates the induction of peripherally derived Treg cells during oral tolerance.
Edwards JP; Hand TW; Morais da Fonseca D; Glass DD; Belkaid Y; Shevach EM
Eur J Immunol; 2016 Jun; 46(6):1480-9. PubMed ID: 27062243
[TBL] [Abstract][Full Text] [Related]
13. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
14. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
[TBL] [Abstract][Full Text] [Related]
15. Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity.
Nakagawa H; Sido JM; Reyes EE; Kiers V; Cantor H; Kim HJ
Proc Natl Acad Sci U S A; 2016 May; 113(22):6248-53. PubMed ID: 27185917
[TBL] [Abstract][Full Text] [Related]
16. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
17. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous Intestinal Tumorigenesis in Apc (/Min+) Mice Requires Altered T Cell Development with IL-17A.
Chae WJ; Bothwell AL
J Immunol Res; 2015; 2015():860106. PubMed ID: 26146642
[TBL] [Abstract][Full Text] [Related]
19. Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia.
Kim SY; Johns SC; Gupta P; Varki N; Fuster MM
Neoplasia; 2021 Nov; 23(11):1137-1143. PubMed ID: 34715561
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells.
Ahmadzadeh M; Rosenberg SA
J Immunol; 2005 May; 174(9):5215-23. PubMed ID: 15843517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
